NCT02610049

Brief Summary

This is a randomized, controlled trial of adjunctive art therapy during cognitive processing therapy for PTSD.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 20, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2017

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 13, 2017

Completed
Last Updated

August 9, 2017

Status Verified

August 1, 2017

Enrollment Period

3.3 years

First QC Date

November 17, 2015

Last Update Submit

August 8, 2017

Conditions

Keywords

PTSD

Outcome Measures

Primary Outcomes (2)

  • PTSD Symptoms assessed by PCL-M score

    PTSD symptoms will be measured by PCL-M score

    8-12 weeks

  • Depression Symptoms assessed by Beck Depression Inventory-II

    Beck Depression Inventory-II will be used to measure depression

    8-12 weeks

Secondary Outcomes (2)

  • Treatment Satisfaction assessed by Likert scale

    8-12 weeks

  • Treatment completion assessed by dropout rate

    8-12 weeks

Study Arms (3)

Control

ACTIVE COMPARATOR

Subjects will receive 8 sessions of Cognitive Processing Therapy.

Behavioral: Cognitive Processing therapy

Experimental

EXPERIMENTAL

Subjects will receive 8 sessions of CPT + Art Therapy 8 sessions of individual therapy.

Behavioral: Art + CPT

Experimental 2

EXPERIMENTAL

Subject to receive 8 sessions of individual therapy for Art + CPT Cognitive Processing Therapy intervention pre-specified to be administered separately.

Behavioral: CPT + Art Therapy

Interventions

8 sessions of standard CPT from CPT manual developed by Dr. S Resick, Monson \& Chard (11/2010)

Also known as: CPT
Control
Art + CPTBEHAVIORAL

8 sessions of individual therapy of mixes techniques Art + CPT 8 sessions of standard CPT (same 8 as in control group) from manual developed by Dr.s Resick, Monson \& Chard (11/2010)

Experimental

Subjects to complete 8 sessions of standard Cognitive Processing Therapy from manual developed by Dr. S. Resick, Monson \& Chard (1/2010) CPT + Art Therapy of mixed individual techniques

Experimental 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PCL-M initial score \>= 50;
  • Both genders,
  • All ethnicities,
  • Veterans in treatment for PTSD,

You may not qualify if:

  • No active substance use disorder,
  • No active suicidal or homicidal ideation,
  • No psychosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hampton VA Medical Center

Hampton, Virginia, 23667, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Interventions

2-cyclohexylidenhydrazo-4-phenyl-thiazoleReproductive Techniques, AssistedArt Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Reproductive TechniquesTherapeuticsInvestigative TechniquesSensory Art TherapiesComplementary TherapiesRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Barbara Cross, Ph.D., FNP

    IRB Chair

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2015

First Posted

November 20, 2015

Study Start

November 1, 2013

Primary Completion

February 3, 2017

Study Completion

February 13, 2017

Last Updated

August 9, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be made available to other researchers. Aggregated data and de-identified data could be potentially be shared at a future date.

Locations